+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioresorbable Bone-graft Substitute Market - Global Forecast 2026-2032- Product Image
Bioresorbable Bone-graft Substitute Market - Global Forecast 2026-2032- Product Image
Sale

Bioresorbable Bone-graft Substitute Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6079308
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioresorbable Bone-graft Substitute Market is projected to reach USD 1.59 Billion in 2026. It is expected to continue growing at a CAGR of 15.08%, reaching USD 3.79 Billion by 2032.

Bioresorbable Bone-Graft Substitutes: Executive Overview

Bioresorbable bone-graft substitutes are designed to support bone healing while gradually breaking down and being replaced by regenerated tissue. Their relevance is linked to reconstructive surgery, trauma care, dental and maxillofacial procedures, and evolving approaches to reducing permanent implant burden. Clinical suitability depends on defect characteristics, mechanical requirements, handling properties, degradation behavior, and evidence supporting safety and healing outcomes.

Clinical Integration Is Shaping the Competitive Landscape

The field is shifting from material novelty toward clinically integrated solutions. Developers and providers are emphasizing predictable resorption, structural performance, biocompatibility, ease of placement, and compatibility with minimally invasive techniques. Adoption is also influenced by surgeon familiarity, institutional protocols, reimbursement conditions, regulatory requirements, and the quality of comparative clinical evidence. Standardized evaluation of degradation and bone formation remains important for broader confidence.

Artificial Intelligence Strengthens Evidence, Design, and Workflow Decisions

Artificial intelligence can support this field by analyzing imaging, identifying defect characteristics, assisting patient-specific planning, and improving postoperative assessment. Machine-learning tools may also help researchers evaluate material composition, porosity, degradation patterns, and interactions with biological tissues. Practical value depends on representative datasets, transparent validation, clinical oversight, and compliance with medical-device requirements. AI should augment-not replace-surgeon judgment and prospective clinical evidence.

Regional Insights: Regulation, Infrastructure, and Clinical Practice Vary

North America is characterized by advanced orthopedic infrastructure, evidence-focused adoption, and active use of digital planning. Europe combines sophisticated clinical research with harmonized, yet demanding, regulatory and quality expectations. Asia-Pacific includes strong manufacturing and research capabilities alongside varied healthcare access and regulatory pathways. Latin America is influenced by uneven hospital resources, import dependence, and the need for cost-conscious solutions. The Middle East is supported by expanding specialist care in selected hubs, while Africa presents substantial unmet clinical need alongside constraints in procurement, training, and surgical capacity.

Group Insights: Economic and Regulatory Blocs Create Distinct Adoption Contexts

ASEAN markets reflect diverse healthcare systems and regulatory maturity, making local registration and distribution capabilities important. BRICS economies combine significant clinical need with varied domestic manufacturing, reimbursement, and procurement conditions. The European Union benefits from coordinated policy structures but requires rigorous conformity and post-market processes. G7 countries generally possess strong research ecosystems and specialist care capacity. GCC states are investing in advanced healthcare infrastructure and referral centers, while NATO members span highly diverse health systems but often emphasize quality, readiness, and resilient medical supply chains.

Country Insights: National Priorities Determine Clinical Uptake

Australia and Canada combine specialist expertise with geographically distributed care challenges. Brazil, Mexico, India, Russia, and South Africa must balance advanced urban treatment with broader access and procurement constraints. China, Japan, and South Korea have substantial medical-technology and research capabilities, with national regulatory and reimbursement considerations shaping adoption. France, Germany, Italy, Spain, and the United Kingdom emphasize clinical evidence, quality systems, and health-service value, while the United States places strong weight on regulatory documentation, physician adoption, hospital economics, and outcomes-based evaluation.

Actions for Leaders: Build Evidence, Usability, and Access Together

Industry leaders should prioritize indication-specific clinical evidence that compares healing, complications, reoperation, handling, and resorption outcomes against accepted alternatives. Product development should align material properties with the mechanical and biological demands of each procedure, supported by robust manufacturing controls and transparent degradation data. Commercial strategies should address surgeon training, imaging and planning workflows, hospital value analysis, and reimbursement documentation. Regional execution should use compliant distribution, local clinical partnerships, and post-market surveillance capable of identifying performance differences across patient populations and care settings.

Research Methodology: Evidence-Led Interpretation of Market Drivers

This executive summary uses the defined market scope of bioresorbable bone-graft substitutes and synthesizes established considerations in biomaterials, orthopedic and reconstructive practice, medical-device regulation, healthcare delivery, and digital clinical tools. Insights are organized across the specified regions, economic and security groups, and countries. The analysis emphasizes qualitative, verifiable drivers and constraints, including clinical utility, evidence requirements, infrastructure, access, regulation, and workflow integration. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments.

Conclusion: Clinical Proof and System Fit Will Define Sustainable Adoption

Bioresorbable bone-graft substitutes have a role in the broader movement toward restorative, procedure-specific, and biologically integrated care. Their long-term relevance will depend less on resorption alone than on demonstrated healing outcomes, dependable handling, appropriate mechanical performance, safe degradation, and fit with real-world surgical workflows. Leaders that combine rigorous evidence with clinician education, regulatory discipline, regional access planning, and responsible digital innovation will be better positioned to support durable clinical adoption.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bioresorbable Bone-graft Substitute Market, by Delivery Form
7.1. Introduction
7.2. Blocks
7.3. Granules
7.4. Powder
7.5. Putty
7.6. Sponges
8. Bioresorbable Bone-graft Substitute Market, by Surgical Application
8.1. Introduction
8.2. Dental Surgery
8.3. Orthopedic Surgery
8.4. Spinal Fusion
8.5. Trauma Repair
9. Bioresorbable Bone-graft Substitute Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Dental Clinics
9.4. Hospitals
9.5. Research Institutes
9.6. Specialty Clinics
10. Bioresorbable Bone-graft Substitute Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Bioresorbable Bone-graft Substitute Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Bioresorbable Bone-graft Substitute Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Alphatec Holdings Inc.
14.2. Baxter International Inc.
14.3. Globus Medical Inc.
14.4. Integra LifeSciences Holdings Corporation
14.5. Johnson & Johnson
14.6. Medtronic plc
14.7. NuVasive Inc.
14.8. Orthofix Medical Inc.
14.9. RTI Surgical Holdings Inc.
14.10. SeaSpine Holdings Corporation
14.11. Smith & Nephew plc
14.12. Stryker Corporation
14.13. Wright Medical Group N.V.
14.14. Xtant Medical Holdings Inc.
14.15. Zimmer Biomet Holdings Inc.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Bioresorbable Bone-graft Substitute Market, Years Considered for the Study
FIGURE 2. Global Bioresorbable Bone-graft Substitute Market, Research Design
FIGURE 3. Global Bioresorbable Bone-graft Substitute Market, Research Framework
FIGURE 4. Global Bioresorbable Bone-graft Substitute Market, Data Triangulation
FIGURE 5. Global Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2025 vs 2032 (%)
FIGURE 7. Global Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2025 vs 2032 (%)
FIGURE 9. Global Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bioresorbable Bone-graft Substitute Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Bioresorbable Bone-graft Substitute Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bioresorbable Bone-graft Substitute Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Bioresorbable Bone-graft Substitute Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bioresorbable Bone-graft Substitute Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Bioresorbable Bone-graft Substitute Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Bioresorbable Bone-graft Substitute Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Bioresorbable Bone-graft Substitute Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Bioresorbable Bone-graft Substitute Market Segmentation & Coverage
TABLE 2. Global Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 4. Global Blocks Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Blocks Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Blocks Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Granules Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Putty Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Putty Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Putty Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Sponges Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Sponges Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Sponges Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 20. Global Dental Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Dental Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Dental Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Orthopedic Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Orthopedic Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Orthopedic Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Spinal Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Spinal Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Spinal Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Trauma Repair Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Trauma Repair Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Trauma Repair Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 33. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Dental Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Dental Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Dental Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 53. North America Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. North America Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 55. North America Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 56. North America Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 57. Latin America Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Latin America Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 59. Latin America Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 60. Latin America Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Europe Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Europe Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 63. Europe Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 64. Europe Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Middle East Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Middle East Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 67. Middle East Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 68. Middle East Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. Africa Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Africa Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 71. Africa Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 72. Africa Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Global Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. ASEAN Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. ASEAN Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 76. ASEAN Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 77. ASEAN Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. GCC Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. GCC Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 80. GCC Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 81. GCC Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. European Union Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. European Union Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 84. European Union Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 85. European Union Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. BRICS Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. BRICS Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 88. BRICS Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 89. BRICS Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. G7 Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. G7 Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 92. G7 Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 93. G7 Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. NATO Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. NATO Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 96. NATO Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 97. NATO Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Global Bioresorbable Bone-graft Substitute Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. United States Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 100. United States Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 101. United States Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 102. United States Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Canada Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 104. Canada Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 105. Canada Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 106. Canada Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Mexico Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 108. Mexico Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 109. Mexico Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 110. Mexico Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Brazil Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 112. Brazil Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 113. Brazil Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 114. Brazil Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. United Kingdom Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 116. United Kingdom Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 117. United Kingdom Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 118. United Kingdom Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Germany Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 120. Germany Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 121. Germany Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 122. Germany Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. France Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 124. France Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 125. France Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 126. France Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. Russia Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 128. Russia Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 129. Russia Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 130. Russia Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Italy Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 132. Italy Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 133. Italy Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 134. Italy Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Spain Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 136. Spain Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 137. Spain Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 138. Spain Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. China Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 140. China Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 141. China Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 142. China Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. India Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 144. India Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 145. India Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 146. India Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Japan Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 148. Japan Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 149. Japan Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 150. Japan Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Australia Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 152. Australia Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 153. Australia Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 154. Australia Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. South Korea Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
TABLE 156. South Korea Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
TABLE 157. South Korea Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
TABLE 158. South Korea Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Global Bioresorbable Bone-graft Substitute Market Share, by Key Player, 2025
TABLE 160. Global Bioresorbable Bone-graft Substitute Market, Key Experts

Companies Mentioned

  • Alphatec Holdings Inc.
  • Baxter International Inc.
  • Globus Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • NuVasive Inc.
  • Orthofix Medical Inc.
  • RTI Surgical Holdings Inc.
  • SeaSpine Holdings Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group N.V.
  • Xtant Medical Holdings Inc.
  • Zimmer Biomet Holdings Inc.

Related Topics

Related Reports

Natural Dental Bone Graft Substitutes Market - Global Forecast 2026-2032 - Product Image

Natural Dental Bone Graft Substitutes Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Bone Grafts & Substitutes Market - Global Forecast 2026-2032 - Product Image

Bone Grafts & Substitutes Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Bone Graft and Substitutes Market Report by Material Type, Application, End User, and Region 2026-2034 - Product Image

Bone Graft and Substitutes Market Report by Material Type, Application, End User, and Region 2026-2034

  • Report
  • 137 Pages
  • Global
From
Dental Bone Graft Substitutes Market by Type, Application, Product, End User, Region - Global Forecast to 2031 - Product Image

Dental Bone Graft Substitutes Market by Type, Application, Product, End User, Region - Global Forecast to 2031

  • Report
  • 268 Pages
  • Global
From
Dental Membrane and Bone Graft Substitutes Market Size, Share & Trends Analysis Report by Product, Application, Region, and Growth Forecasts, 2026-2033 - Product Image

Dental Membrane and Bone Graft Substitutes Market Size, Share & Trends Analysis Report by Product, Application, Region, and Growth Forecasts, 2026-2033

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.